Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma

This study is part of the management of patients with advanced ovarian and/or peritoneal carcinoma, and/or fallopian tubes (initial treatment) at the Oscar Lambret Center.

Once consent is obtained, pre-registration of patient on the trial is possible during initial care, from diagnosis and before the confirmation of FIGO stage; a trial number is assigned to the patient.

If the diagnosis of advanced invasive ovarian and/or peritoneal and/or fallopian tube carcinoma is confirmed (FIGO stage IIB to IV), the patient is included. On the contrary (FIGO stage IA to IIA, or other disease), patient is not included on the trial and excluded from analysis.

Pre-registration and inclusion are possible the same day if the definitive FIGO stage is confirmed.

However, this project differs from standard care with:

* an additional blood sample, collected once inclusion is confirmed (28ml) * left-over routine samples collected from pre-registration until two years after pre-registration (tumor samples, ascites, zetc.) * questionnaires about quality of life (QLQ-C30, QLQ-OV28) and anxiety (HADS) are completed after pre-registration, then after 3 and 6 courses of systemic treatment (at the time of laparoscopy or surgery), then every 3 months, up to 2 years after pre-registration. Patients can choose printed and/or digital questionnaires. * clinical data are entered into a trial-specific database ; in addition to overall survival, numerous variables will be studied, notably the clinical and socio-economic characteristics of the patients, their planned and effective treatment, the morbidity of treatments, event-free survival, evolution of the quality of life, etc. * Translational research works will be implemented later on left-over routine samples.

• To develop a prospective clinico-biological database of patients with advanced ovarian and/or peritoneal and/or fallopian tube carcinoma included during first-line treatment [Срок оценки: Up to 7 years after the first pre-registration]
• To develop and validate prognostic models of event-free survival (EFS) on patients included prospectively as part of the initial treatment, integrating both patient's and tumor's characteristics, using a multivariate Cox model [Срок оценки: Up to 7 years after the first pre-registration]
• To describe both initial characteristics of the patients and their disease characteristics [Срок оценки: At baseline]
• To describe the therapeutic management of these patients, as planned initially and finally carried out [Срок оценки: Up to 7 years after the first pre-registration]
• To describe the morbidity events of first-line treatments [Срок оценки: Up to 7 years after the first pre-registration]
• To describe the distribution of events (recurrence or progression) on patients who have received platinum treatment [Срок оценки: Up to 7 years after the first pre-registration]
• To estimate overall survival (OS) and event-free survival (EFS) of patients [Срок оценки: Up to 7 years after the first pre-registration]
• To estimate post-relapse overall survival (OS), and post-relapse event-free survival (EFS) of patients [Срок оценки: Up to 7 years after the first pre-registration]
• To assess the quality of life of patients according to the score calculated with the health-related quality of life questionnaire (QLQ-C30) [Срок оценки: After pre-registration, then after 3 and 6 courses of systemic treatment (up to 3 and 6 months), at the time of surgery, then every 3 months up to 2 years after pre-registration]
• To assess the quality of life of patients according to the score calculated with the ovarian cancer module of the health-related quality of life questionnaire (QLQ-OV28) [Срок оценки: After pre-registration, then after 3 and 6 courses of systemic treatment (up to 3 and 6 months), at the time of surgery, then every 3 months up to 2 years after pre-registration]
• To assess the level of anxiety of patients according to the anxiety score calculated with Hospital Anxiety and Depression scale [Срок оценки: After pre-registration, then after 3 and 6 courses of systemic treatment (up to 3 and 6 months), at the time of surgery, then every 3 months up to 2 years after pre-registration]
• To assess the level of depression of patients according to the depression score calculated with Hospital Anxiety and Depression scale [Срок оценки: After pre-registration, then after 3 and 6 courses of systemic treatment (up to 3 and 6 months), at the time of surgery, then every 3 months up to 2 years after pre-registration]